Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,561 to 1,580 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic gene signatures and aberrant pathway activation based on m6A methylation regulators in rheumatoid arthritis. | Front Immunol | 2022 | 36582238 | PubTator, text mining | PubMed |
| lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m6A reader YTHDC2. | Mol Cancer | 2022 | 36581942 | PubTator, text mining | PubMed |
| m6A RNA methylation regulator-based signature for prognostic prediction and its potential immunological role in uterine corpus endometrial carcinoma. | BMC Cancer | 2022 | 36581816 | PubTator, text mining | PubMed |
| METTL14 Regulates Intestine Cellular Senescence through m6A Modification of Lamin B Receptor. | Oxid Med Cell Longev | 2022 | 36578521 | PubTator, text mining | PubMed |
| The Role of N6-Methyladenosine in Inflammatory Diseases. | Oxid Med Cell Longev | 2022 | 36578520 | PubTator, text mining | PubMed |
| Roles of the m6A methyltransferases METTL3, METTL14, and WTAP in pulmonary tuberculosis. | Front Immunol | 2022 | 36569923 | PubTator, text mining | PubMed |
| The malaria parasite chaperonin containing TCP-1 (CCT) complex: Data integration with other CCT proteomes. | Front Mol Biosci | 2022 | 36567946 | PubTator, text mining | PubMed |
| RNA N6-methyladenosine modification mediates downregulation of NR4A1 to facilitate malignancy of cervical cancer. | Cell Biosci | 2022 | 36566195 | PubTator, text mining | PubMed |
| The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets. | Front Oncol | 2022 | 36561529 | PubTator, text mining | PubMed |
| The Transition from Cancer "omics" to "epi-omics" through Next- and Third-Generation Sequencing. | Life (Basel) | 2022 | 36556377 | PubTator, text mining | PubMed |
| The N6-Methyladenosine Regulator ALKBH5 Mediated Stromal Cell-Macrophage Interaction via VEGF Signaling to Promote Recurrent Spontaneous Abortion: A Bioinformatic and In Vitro Study. | Int J Mol Sci | 2022 | 36555463 | PubTator, text mining | PubMed |
| Crosstalk between Methylation and ncRNAs in Breast Cancer: Therapeutic and Diagnostic Implications. | Int J Mol Sci | 2022 | 36555400 | PubTator, text mining | PubMed |
| RNA Epigenetics in Chronic Lung Diseases. | Genes (Basel) | 2022 | 36553648 | PubTator, text mining | PubMed |
| The Role of the m6A RNA Methyltransferase METTL16 in Gene Expression and SAM Homeostasis. | Genes (Basel) | 2022 | 36553579 | PubTator, text mining | PubMed |
| N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer. | Diagnostics (Basel) | 2022 | 36553003 | PubTator, text mining | PubMed |
| Unveiling the Vital Role of Long Non-Coding RNAs in Cardiac Oxidative Stress, Cell Death, and Fibrosis in Diabetic Cardiomyopathy. | Antioxidants (Basel) | 2022 | 36552599 | PubTator, text mining | PubMed |
| The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression. | Cancers (Basel) | 2022 | 36551531 | PubTator, text mining | PubMed |
| One-Carbon and Polyamine Metabolism as Cancer Therapy Targets. | Biomolecules | 2022 | 36551330 | PubTator, text mining | PubMed |
| Role of Pyroptosis in Intervertebral Disc Degeneration and Its Therapeutic Implications. | Biomolecules | 2022 | 36551232 | PubTator, text mining | PubMed |
| Exon junction complex shapes the m6A epitranscriptome. | Nat Commun | 2022 | 36550132 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=79